See every side of every news story
Published loading...Updated

Weight-loss drugs reduce risk of Alzheimer’s, large study shows

  • A new study found that GLP-1 medications, used for weight loss and diabetes, reduce the risk of dementia and other neurocognitive disorders by 12%.
  • The research showed that users of GLP-1 drugs experienced lower risks for 42 health outcomes but higher risks for 19, including nausea and vomiting.
  • The study, which analyzed data from 2.4 million people, noted that results may not apply to all demographics as the majority were older, White, and male.
  • Experts suggest further studies are needed to explore the full benefits and risks of GLP-1 medications, emphasizing individualized discussions with healthcare providers.
Insights by Ground AI
Does this summary seem wrong?

131 Articles

All
Left
19
Center
45
Right
10
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 61% of the sources are Center
61% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Nature broke the news in United Kingdom on Monday, January 20, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.